WHO Backs Pfizer’s Paxlovid For High-Risk COVID-19 Patients
But Access Obstacles Remain In Lower-Income Countries
Executive Summary
An international group of experts has issued new guidance on the use of therapeutics in patients with non-severe COVID-19.
You may also be interested in...
Global COVID-19 Access Program Facing ‘Financial Crisis’
ACT-A, an initiative led by the World Health Organization and involving international health agencies, has significantly improved access to COVID-19 medical countermeasures in lower-income countries. However, further progress could be hindered by a funding shortfall, and ACT-A has urged donors to contribute their fair share.
EU Boosts COVID-19 Vaccine Supplies With Moderna & HIPRA Deals
New supply arrangements with the two firms are expected to offer greater protection to people in Europe as the autumn/winter season approaches. The EU’s health crisis preparedness body HERA has also identified its “top three health threats.”
Aspen Setback Illustrates Need For Africa To Build Up Vaccines Market
A coordinated effort will be needed if Africa is to increase its manufacturing capacity and ensure a market for domestically produced vaccines.